Another potential explanation for the differential reduction in insulinotropic potency of GIP (much impaired) and GLP-1 (mildly reduced) in type 2 diabetes is that GLP-1 can activate the G proteins Gaq and Gas, whereas GIP can only activate Gas. The gene discussed is GNAQ; the disease is type 2 diabetes mellitus.